Extrahepatic Cholangiocarcinoma: Genomic Variables Associated With Anatomic Location and Outcome
JCO Precision Oncology · 2024
DOI: 10.1200/po.24.00206 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Precision Oncology, 2024. Verfasst von William A Preston und 15 weiteren Autor:innen. Beteiligte Einrichtung: Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY. Hauptthemen laut MEDLINE: Bile Duct Neoplasms, Cholangiocarcinoma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
PURPOSE This study aimed to define genomic differences between perihilar cholangiocarcinoma (PCA) and distal cholangiocarcinoma (DCA) and identify genomic determinants of survival. MATERIALS AND METHODS Consecutive patients with ECA with tissue for targeted next-generation sequencing were analyzed, stratified by anatomic site (PCA/DCA), disease extent, and treatment. Associations between genomic alterations, clinicopathologic features, and outcomes were analyzed using Cox proportional hazards regression to compare survival. RESULTS In total, 224 patients diagnosed between 2004 and 2022 (n = 127 PCA; n = 97 DCA) met inclusion criteria. The median survival was 29 months (43 after resection and 17 from diagnosis for unresectable disease). Compared with PCA, DCA was enriched in TP53alt (alterations; 69% v 33%; Q < 0.01), epigenetic pathway alterations (45% v 29%; Q = 0.041), and had more total altered pathways (median 3 v 2; Q < 0.01). KRASalt frequency was similar between PCA (36%) and DCA (37%); however, DCA was enriched in KRAS G12D (19% v 9%; P = .002). No other clinicopathologic or genomic variables distinguished subtypes. In resected patients, no genomic alterations were associated with outcome. However, in unresectable patients, CDKN2Aalt (hazard ratio [HR], 2.59 [1.48 to 4.52]) and APCalt (HR, 5.11 [1.96 to 13.3]) were associated with reduced survival. For the entire cohort, irresectability (HR, 3.13 [2.25 to 4.36]), CDKN2Aalt (HR, 1.80 [1.80 to 2.68]), and APCalt (HR, 2.00 [1.04 to 3.87]) were associated with poor survival. CONCLUSION CDKN2Aalt and APCalt were associated with poor survival in ECA, primarily in advanced disease. As PCA and DCA were genetically similar, coanalysis of PCA and DCA in future genomic studies is reasonable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
- Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
- Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
- Department of Medicine, Weill Cornell Medicine, New York, NY.
- Trinity College Dublin, Dublin, Ireland.
- The David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY.
ORCID-Profile: William A Preston, Esther Drill, Rebecca Gelfer, James J Harding, Eileen M O'Reilly, Andrea Cercek, Ghassan Abou-Alfa, Wungki Park, Kevin C Soares, Alice Wei, William R Jarnagin
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Preston, W. A., Drill, E., Boerner, T., Gelfer, R., Harding, J. J., O'Reilly, E. M., Cercek, A., Abou-Alfa, G., Park, W., Balachandran, V. P., Drebin, J., Soares, K. C., Wei, A., Kingham, T. P., D'Angelica, M. I., & Jarnagin, W. R. (2024). Extrahepatic Cholangiocarcinoma: Genomic Variables Associated With Anatomic Location and Outcome. JCO Precision Oncology. https://doi.org/10.1200/po.24.00206
Vancouver
Preston WA, Drill E, Boerner T, Gelfer R, Harding JJ, O'Reilly EM, et al. Extrahepatic Cholangiocarcinoma: Genomic Variables Associated With Anatomic Location and Outcome. JCO Precision Oncology. 2024. doi:10.1200/po.24.00206
BibTeX
@article{Preston2024,
author = {Preston, William A and Drill, Esther and Boerner, Thomas and Gelfer, Rebecca and Harding, James J and O'Reilly, Eileen M and Cercek, Andrea and Abou-Alfa, Ghassan and Park, Wungki and Balachandran, Vinod P and Drebin, Jeffrey and Soares, Kevin C and Wei, Alice and Kingham, T Peter and D'Angelica, Michael I and Jarnagin, William R},
title = {Extrahepatic Cholangiocarcinoma: Genomic Variables Associated With Anatomic Location and Outcome},
journal = {JCO Precision Oncology},
year = {2024},
doi = {10.1200/po.24.00206}
}
EUVIMED